Seeking Alpha

Trinity Biotech revenue comes in light

  • Trinity Biotech (TRIB -3.1%) Q2: Diluted EPS (ex-Medical Devise Excise Tax) of $0.176.
  • Revenue of $21.3M (+2.4% Y/Y) misses by $0.7M.
  • The company also says it is acquiring Immco Diagnostics for $32.75M, a deal TRIB says will be "immediately earnings accretive." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: